Related Experiment Video
Updated: Aug 14, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
C-reactive protein and its role in the pathogenesis of myocardial infarction
1Centre for Amyloidosis and Acute Phase Proteins, Department of Medicine, Royal Free and University College Medical School, London, UK. m.pepys@rfc.ucl.ac.uk
Insights
C-reactive protein (CRP) aids in diagnosing inflammatory conditions. Elevated CRP levels, detected by high-sensitivity assays, now predict cardiovascular events and may be a therapeutic target for atherosclerosis.
Area of Science:
- Biochemistry
- Immunology
- Cardiology
Background:
- C-reactive protein (CRP) is a classical acute phase reactant.
- CRP aids in diagnosing and managing infective and inflammatory conditions.
- High-sensitivity CRP assays strengthen the view of atherosclerosis as an inflammatory disease.
Purpose of the Study:
- To review the role of CRP in cardiovascular disease.
- To explore CRP's predictive value for cardiovascular events.
- To discuss CRP as a potential therapeutic target in atherosclerosis.
Main Methods:
- Review of existing literature and epidemiological surveys.
- Analysis of data from studies using high-sensitivity CRP assays.
- Synthesis of evidence on CRP's role in atherosclerosis pathogenesis.
Main Results:
- Elevated CRP predicts poor outcomes in unstable coronary syndromes and myocardial infarction.
- Baseline CRP levels predict future cardiovascular events in at-risk and healthy individuals.
- Evidence suggests a direct role for CRP in atherosclerosis and post-myocardial infarction inflammation.
Conclusions:
- CRP is a significant predictor of cardiovascular events.
- CRP may play a direct role in the pathogenesis of atherosclerosis.
- CRP presents a potential future therapeutic target for cardiovascular diseases.
Abstract:
C-reactive protein (CRP), the classical acute phase reactant, has for some time contributed to both the diagnosis and management of a wide range of infective and inflammatory conditions. More recently with the advent of high sensitivity assays, the hypothesis that atherosclerosis is an inflammatory disease has been strengthened. "Elevated" CRP values predict a poor outcome for patients suffering from unstable coronary syndromes as well myocardial infarction, and large epidemiological surveys have shown that baseline values of CRP can predict future cardiovascular events in those at risk, as well as those otherwise well. Increasingly a direct role for CRP in the pathogenesis of atherosclerosis and post-myocardial infarction inflammation has also been suggested, and CRP itself may prove to be a future therapeutic target in the treatment of atherosclerosis and its consequences.
More Related Videos
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis III: Medical Management
Cardiomyopathy IV: Restrictive Cardiomyopathy

